| Name | Vicapsys Life Sciences, Inc. |
|---|---|
| CIK | 0001468639 |
| Tickers | VICP |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 621153426 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | FL FL |
| Phone | 470-514-4013 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
92 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-27 | 15-12G | form15-12g.htm | 0001641172-25-000877 | 000-56145 | 25777002 | 34 | 18623 | |||
| 2025-03-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-043406 | 005-85123 | 25761863 | 34 | 110062 | |||
| 2025-03-21 | 3 | 3 | 0000950170-25-043405 | 8381 | ||||||
| 2025-01-10 | 10-Q | form10-q.htm | 0001493152-25-001779 | 000-56145 | 25523887 | 34 | 3508373 | 1 | 1 | |
| 2025-01-10 | 10-Q | form10-q.htm | 0001493152-25-001776 | 000-56145 | 25523846 | 34 | 3435005 | 1 | 1 | |
| 2025-01-10 | 10-Q | form10-q.htm | 0001493152-25-001743 | 000-56145 | 25523593 | 34 | 3189024 | 1 | 1 | |
| 2024-10-21 | 10-K | form10-k.htm | 0001493152-24-041809 | 000-56145 | 241384207 | 34 | 5183084 | 1 | 1 | |
| 2024-06-27 | SEC STAFF ACTION | filename1.pdf | 9999999997-24-003035 | 6899 | ||||||
| 2023-12-27 | 8-K | form8-k.htm | 1.01,2.03,9.01 | 0001493152-23-046217 | 000-56145 | 231517202 | 34 | 231641 | 1 | 1 |
| 2023-11-14 | 10-Q | form10-q.htm | 0001493152-23-040951 | 000-56145 | 231404417 | 34 | 3652702 | 1 | 1 | |
| 2023-08-14 | 10-Q | form10-q.htm | 0001493152-23-028151 | 000-56145 | 231167405 | 34 | 3543382 | 1 | 1 | |
| 2023-08-09 | DEF 14C | def14c.htm | 0001493152-23-027339 | 000-56145 | 231154967 | 34 | 182231 | |||
| 2023-07-28 | PRE 14C | formpre14c.htm | 0001493152-23-025916 | 000-56145 | 231123850 | 34 | 182237 | |||
| 2023-07-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-23-024442 | 021-486774 | 231086349 | 33 | 10694 | ||
| 2023-06-30 | S-1 | forms-1.htm | 0001493152-23-023181 | 333-273109 | 231064273 | 33 | 7187578 | 1 | 1 | |
| 2023-06-30 | 8-K | form8-k.htm | 1.01,2.03,3.02,9.01 | 0001493152-23-023183 | 000-56145 | 231062859 | 34 | 615583 | 1 | 1 |
| 2023-06-02 | 8-K | form8-k.htm | 1.01,9.01 | 0001493152-23-019905 | 000-56145 | 23987822 | 34 | 286015 | 1 | 1 |
| 2023-05-18 | 8-K/A | form8-ka.htm | 4.01,9.01 | 0001493152-23-018151 | 000-56145 | 23937106 | 34 | 218181 | 1 | 1 |
| 2023-05-17 | 8-K | form8-k.htm | 4.01,9.01 | 0001493152-23-017970 | 000-56145 | 23932640 | 34 | 363594 | 1 | 1 |
| 2023-05-15 | 10-Q | form10-q.htm | 0001493152-23-017138 | 000-56145 | 23920675 | 34 | 3029541 | 1 | 1 | |
| 2023-04-14 | 10-K | form10-k.htm | 0001493152-23-012267 | 000-56145 | 23820924 | 34 | 5223268 | 1 | 1 | |
| 2023-03-31 | NT 10-K | formnt10-k.htm | 0001493152-23-010247 | 000-56145 | 23787508 | 34 | 36871 | |||
| 2023-01-12 | 8-K | form8-k.htm | 5.02,9.01 | 0001493152-23-001296 | 000-56145 | 23526018 | 34 | 446194 | 1 | 1 |
| 2022-11-21 | DEF 14C | formdef14c.htm | 0001493152-22-033087 | 000-56145 | 221405491 | 34 | 313444 | |||
| 2022-11-21 | 10-Q | form10-q.htm | 0001493152-22-033024 | 000-56145 | 221403882 | 34 | 3832626 | 1 | 1 | |
| 2022-11-14 | NT 10-Q | formnt10q.htm | 0001493152-22-032168 | 000-56145 | 221386880 | 34 | 36747 | |||
| 2022-09-28 | 8-K | form8-k.htm | 5.02 | 0001493152-22-027017 | 000-56145 | 221276087 | 34 | 208067 | 1 | 1 |
| 2022-08-16 | 10-Q | form10-q.htm | 0001493152-22-023207 | 000-56145 | 221170669 | 34 | 3642594 | 1 | 1 | |
| 2022-08-15 | NT 10-Q | formnt10-q.htm | 0001493152-22-022969 | 000-56145 | 221166676 | 34 | 37040 | |||
| 2022-05-17 | DEF 14C | formdef14c.htm | 0001493152-22-014135 | 000-56145 | 22932948 | 34 | 185325 | |||
| 2022-05-13 | 10-Q | form10-q.htm | 0001493152-22-013375 | 000-56145 | 22923933 | 34 | 4630878 | 1 | 1 | |
| 2022-05-06 | PRE 14C | formpre14c.htm | 0001493152-22-012369 | 000-56145 | 22900709 | 34 | 185271 | |||
| 2022-04-12 | 8-K | form8-k.htm | 5.02,8.01,9.01 | 0001493152-22-009690 | 000-56145 | 22822309 | 34 | 220080 | 1 | 1 |
| 2022-03-16 | 10-K | form10-k.htm | 0001493152-22-006994 | 000-56145 | 22745371 | 34 | 4096884 | 1 | 1 | |
| 2021-11-12 | 10-Q | form10-q.htm | 0001493152-21-027976 | 000-56145 | 211399267 | 34 | 3314941 | 1 | 1 | |
| 2021-09-20 | 10-Q | form10-q.htm | 0001493152-21-023189 | 000-56145 | 211264180 | 34 | 3408866 | 1 | 1 | |
| 2021-09-20 | 10-Q | form10-q.htm | 0001493152-21-023170 | 000-56145 | 211263963 | 34 | 2478567 | 1 | ||
| 2021-09-17 | 10-K | form10-k.htm | 0001493152-21-022984 | 000-56145 | 211260054 | 34 | 3983570 | 1 | ||
| 2021-09-13 | 10-Q | form10-q.htm | 0001493152-21-022517 | 000-56145 | 211249085 | 34 | 2899089 | 1 | ||
| 2021-09-09 | 10-Q | form10-q.htm | 0001493152-21-022270 | 000-56145 | 211244228 | 34 | 2983737 | 1 | ||
| 2020-05-15 | 10-Q | form10-q.htm | 0001493152-20-009028 | 000-56145 | 20883765 | 34 | 2301028 | 1 | ||
| 2020-04-06 | UPLOAD | filename1.pdf | 0000000000-20-002930 | 39586 | ||||||
| 2020-03-30 | 10-12G/A | form10-12ga.htm | 0001493152-20-005283 | 000-56145 | 20758356 | 34 | 1524667 | |||
| 2020-03-27 | UPLOAD | filename1.pdf | 0000000000-20-002683 | 42296 | ||||||
| 2020-03-20 | CORRESP | filename1.htm | 0001493152-20-004429 | 55569 | ||||||
| 2020-03-20 | 10-12G/A | form10-12ga.htm | 0001493152-20-004426 | 000-56145 | 20731919 | 34 | 1954855 | |||
| 2020-03-11 | UPLOAD | filename1.pdf | 0000000000-20-002161 | 57111 | ||||||
| 2020-02-12 | 10-12G | form10-12g.htm | 0001493152-20-002044 | 000-56145 | 20603501 | 34 | 25736488 | |||
| 2018-02-16 | D | xslFormDX01/primary_doc.xml | 06b | 0001716888-18-000001 | 021-305893 | 18621055 | 33 | 12947 | ||
| 2018-01-08 | D | xslFormDX01/primary_doc.xml | 06b | 0001475158-18-000001 | 021-302620 | 18515583 | 33 | 11560 | ||
| 2016-11-07 | 15-15D | form15-15d.htm | 0001493152-16-014543 | 333-160700 | 161976175 | 34 | 14956 | |||
| 2010-09-08 | 4 | xslF345X03/v196190_ex.xml | 0001144204-10-048603 | 6944 | ||||||
| 2010-08-24 | 10-Q | v194949_10q.htm | 0001144204-10-046358 | 333-160700 | 101034924 | 34 | 784022 | |||
| 2010-08-16 | NT 10-Q | v194163_12b-25.htm | 0001144204-10-044269 | 333-160700 | 101018321 | 34 | 29751 | |||
| 2010-08-16 | 4 | xslF345X03/v193357_ex.xml | 0001144204-10-044155 | 7018 | ||||||
| 2010-07-29 | 8-K/A | v191547_8ka.htm | 2.01,9.01 | 0001144204-10-040083 | 333-160700 | 10978096 | 34 | 1321400 | ||
| 2010-07-01 | 8-K | v189648_8k.htm | 5.02,9.01 | 0001144204-10-036040 | 333-160700 | 10929649 | 34 | 28703 | ||
| 2010-06-22 | 10-Q | v187901_10q.htm | 0001144204-10-034513 | 333-160700 | 10910084 | 34 | 583453 | |||
| 2010-05-25 | D | xslFormDX01/primary_doc.xml | 06 | 0001144204-10-030156 | 021-142513 | 10856017 | 33 | 9808 | ||
| 2010-05-24 | 10-K | v185945_10k.htm | 0001144204-10-029858 | 333-160700 | 10853729 | 34 | 1523349 | |||
| 2010-05-24 | D | xslFormDX01/primary_doc.xml | 06 | 0001144204-10-029807 | 021-142456 | 10853385 | 33 | 9862 | ||
| 2010-05-20 | SC 13G | v185877_sc13g.htm | 0001144204-10-029190 | 005-85123 | 10847254 | 34 | 43789 | |||
| 2010-05-20 | 3 | xslF345X02/v185880_ex.xml | 0001144204-10-029178 | 3736 | ||||||
| 2010-05-18 | 8-K | v185727_8k.htm | 2.01,3.02,9.01 | 0001144204-10-028744 | 333-160700 | 10841939 | 34 | 1080125 | ||
| 2010-05-17 | NT 10-Q | v185542_nt10q.txt | 0001144204-10-028070 | 333-160700 | 10837269 | 34 | 6358 | |||
| 2010-04-26 | 8-K | v182167_8k.htm | 1.02,5.02 | 0001144204-10-022071 | 333-160700 | 10769623 | 34 | 23794 | ||
| 2010-04-12 | 8-K | v180789_8k.htm | 5.02,9.01 | 0001144204-10-019600 | 333-160700 | 10745525 | 34 | 24757 | ||
| 2010-04-02 | NT 10-K/A | v180027_nt10ka.htm | 0001144204-10-018309 | 333-160700 | 10728300 | 34 | 40305 | |||
| 2010-04-01 | NT 10-K | v179783_nt10k.htm | 0001144204-10-017956 | 333-160700 | 10723677 | 34 | 39908 | |||
| 2010-01-29 | 4/A | xslF345X03/v172686_ex.xml | 0001144204-10-004368 | 4612 | ||||||
| 2010-01-25 | 4 | xslF345X03/v172120_ex.xml | 0001144204-10-003360 | 14567 | ||||||
| 2009-12-22 | SC 13D | SCHEDULE 13D | 0000950123-09-072385 | 005-85123 | 091253145 | 34 | 95252 | |||
| 2009-12-14 | 3/A | xslF345X02/v168584_ex.xml | 0001144204-09-064364 | 4344 | ||||||
| 2009-12-10 | SC 13D | v168732_sc13d.htm | 0001144204-09-064053 | 005-85123 | 091234247 | 34 | 69912 | |||
| 2009-12-09 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2009-12-09 09:30:00 | 9999999995-09-003414 | 333-160700 | 091232146 | 33 | 2079 | ||
| 2009-12-09 | 8-K | v168604_8k.htm | 8.01,9.01 | 0001144204-09-063848 | 333-160700 | 091231256 | 34 | 55045 | ||
| 2009-12-09 | 3 | xslF345X02/v168343_ex.xml | 0001144204-09-063801 | 4787 | ||||||
| 2009-12-09 | UPLOAD | filename1.pdf | 0000000000-09-069519 | 49101 | ||||||
| 2009-12-09 | UPLOAD | filename1.pdf | 0000000000-09-069433 | 88727 | ||||||
| 2009-12-09 | 3 | xslF345X02/v168337_ex.xml | 0001144204-09-063763 | 3706 | ||||||
| 2009-12-09 | 3 | xslF345X02/v168341_ex.xml | 0001144204-09-063756 | 4224 | ||||||
| 2009-12-09 | 3 | xslF345X02/v168340_ex.xml | 0001144204-09-063740 | 4746 | ||||||
| 2009-12-09 | 3 | xslF345X02/v168339_ex.xml | 0001144204-09-063738 | 4141 | ||||||
| 2009-12-09 | 3 | xslF345X02/v168338_ex.xml | 0001144204-09-063736 | 5756 | ||||||
| 2009-12-09 | 3 | xslF345X02/v168334_ex.xml | 0001144204-09-063724 | 6476 | ||||||
| 2009-12-03 | CORRESP | filename1.htm | 0001144204-09-062950 | 13145 | ||||||
| 2009-11-20 | S-1/A | v166988_s1a.htm | 0001144204-09-061132 | 333-160700 | 091197924 | 33 | 3405594 | |||
| 2009-10-27 | S-1/A | v163537_s1a.htm | 0001144204-09-054681 | 333-160700 | 091137884 | 33 | 3541222 | |||
| 2009-09-29 | CORRESP | filename1.htm | 0001144204-09-050635 | 142702 | ||||||
| 2009-09-29 | S-1/A | v161152_s1a.htm | 0001144204-09-050580 | 333-160700 | 091092913 | 33 | 50344027 | |||
| 2009-08-11 | UPLOAD | filename1.pdf | 0000000000-09-043497 | 132137 | ||||||
| 2009-07-17 | S-1 | v154885_s1.htm | 0001144204-09-037832 | 333-160700 | 09953458 | 33 | 21843002 |
One latest value per concept from companyfacts (172 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 32.37M | 2024-12-13 | 2024 | Q1 | 10-Q | 2025-01-10 | 0001493152-25-001743 | |
| dei | EntityListingParValuePerShare | Entity Listing, Par Value Per Share | USD/shares | 0.001 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| dei | EntityPublicFloat | Entity Public Float | USD | 4.66M | 2024-06-30 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 537,449 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 272,317 | 2022-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 961,708 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 115,312 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 14.37M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 14.07M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 27,844 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2025-01-10 | 0001493152-25-001743 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 3,548 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 20,697 | 2023-01-01 | 2023-03-31 | 2024 | Q1 | 10-Q | 2025-01-10 | 0001493152-25-001743 |
| us-gaap | AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net | USD | 4,326 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001493152-22-006994 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 50,574 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 115,082 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits | Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units | USD | 2,163 | 2021-01-01 | 2021-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0001493152-22-013375 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 3.18M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | Assets | Assets | USD | 89,569 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 89,569 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | Cash | Cash | USD | 26,210 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 89,569 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 89,569 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 80,147 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Financing Activities, Discontinued Operations | USD | 176,600 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Operating Activities, Discontinued Operations | USD | -132,830 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.5 | 2022-07-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 32.37M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 32.37M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 32,371 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 50,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | ConversionOfStockSharesIssued1 | Conversion of Stock, Shares Issued | shares | 597,281 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0001493152-23-028151 |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 511,403 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 328,571 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | DebtInstrumentAnnualPrincipalPayment | Debt Instrument, Annual Principal Payment | USD | 363,000 | 2023-12-26 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 363,000 | 2023-12-26 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | DebtInstrumentFairValue | Debt Instrument, Fair Value Disclosure | USD | 35,625 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | DebtInstrumentFeeAmount | Debt Instrument, Fee Amount | USD | 83,526 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 50,441 | 2022-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 2.99M | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 2.99M | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | Depreciation | Depreciation | USD | 30,364 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share | USD/shares | -0.03 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities | Disposal Group, Including Discontinued Operation, Accrued Liabilities | USD | 277,083 | 2018-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense | Disposal Group, Including Discontinued Operation, General and Administrative Expense | USD | 58,215 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOperatingExpense | Disposal Group, Including Discontinued Operation, Operating Expense | USD | 425,787 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationRevenue | Disposal Group, Including Discontinued Operation, Revenue | USD | 50,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | DueToRelatedPartiesCurrentAndNoncurrent | Due to Related Parties | USD | 875,177 | 2020-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.02 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.01 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001493152-22-006994 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.02 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.2 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0001493152-22-013375 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 215,025 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001493152-22-006994 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 31,299 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 7,822 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 215,035 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 31,299 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 31,299 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 31,299 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 371,520 | 2021-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 | |
| us-gaap | FiniteLivedPatentsGross | Finite-Lived Patents, Gross | USD | 492,514 | 2021-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 | |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 100,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-09-20 | 0001493152-21-023170 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | 100,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-20 | 0001493152-21-023189 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -86,300 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 41,819 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 340,231 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 340,231 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -752,670 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -765,844 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -0.1 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -375,787 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 100,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 456 | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 243,898 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 4,346 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -248,244 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 1.18M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 26,208 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0001493152-22-013375 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | 272,522 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 269,353 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 115,312 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | IncreaseDecreaseInNotesPayableCurrent | Increase (Decrease) in Notes Payable, Current | USD | -6,167 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2025-01-10 | 0001493152-25-001743 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | -30,234 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 1.06M | 2021-01-01 | 2021-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0001493152-22-013375 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 2.68M | 2021-01-01 | 2021-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0001493152-22-013375 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 371,520 | 2021-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 | |
| us-gaap | InterestExpense | Interest Expense | USD | 10,660 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001493152-23-040951 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 5,156 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 81,412 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 212 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 16,626 | 2019-01-01 | 2019-03-31 | 2020 | Q1 | 10-Q | 2020-05-15 | 0001493152-20-009028 |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 89,569 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 2.74M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 123,834 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 971,500 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 100,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -43,687 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -262,897 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -752,670 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -752,670 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -167,047 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-13 | 0001493152-22-013375 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -167,712 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | OfficersCompensation | Salary and Wage, Officer, Excluding Cost of Good and Service Sold | USD | 68,450 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2021-09-09 | 0001493152-21-022270 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 584,958 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -584,958 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 13.95M | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 2.93M | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 | |
| us-gaap | OtherIncome | Other Income | USD | 100,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001493152-21-027976 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 100,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 22,168 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 23,500 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | PreferredStockDividendsAndOtherAdjustments | Preferred Stock Dividends and Other Adjustments | USD | 3,548 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 7.44M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 30,234 | 2023-12-31 | 2024 | Q1 | 10-Q | 2025-01-10 | 0001493152-25-001743 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 7,240 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-12 | 0001493152-21-027976 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 75,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 100,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 36,789 | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 971,500 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 55,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | ProceedsFromOtherShortTermDebt | Proceeds from Other Short-term Debt | USD | 291,010 | 2023-01-01 | 2023-06-30 | 2024 | Q2 | 10-Q | 2025-01-10 | 0001493152-25-001776 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | -41,192 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | ProceedsFromSaleOfEquityMethodInvestments | Proceeds from Sale of Equity Method Investments | USD | 100,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 100,000 | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 341,549 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -492,185 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 6,166 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 14,090 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -17.05M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 100,000 | 2022-03-14 | 2024 | Q1 | 10-Q | 2025-01-10 | 0001493152-25-001743 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 20,697 | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested | USD | 1.5 | 2021-12-31 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | USD | 0 | 2022-08-09 | 2022-08-10 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.95 | 2022-08-09 | 2022-08-10 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.029 | 2022-08-09 | 2022-08-10 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 2.27 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-16 | 0001493152-22-023207 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.67M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 0.62 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 3.96M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-21 | 0001493152-22-033024 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 550,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001493152-22-006994 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 770,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.5 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 770,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-04-14 | 0001493152-23-012267 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 2.27 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-16 | 0001493152-22-023207 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 2.67M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 0.62 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 1.85 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001493152-22-006994 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 0.25 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001493152-22-006994 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0.25 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | SharesIssued | Shares, Issued | shares | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001493152-23-040951 | |
| us-gaap | ShortTermBankLoansAndNotesPayable | Short-term Bank Loans and Notes Payable | USD | 12,546 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 12,546 | 2024-06-30 | 2024 | Q2 | 10-Q | 2025-01-10 | 0001493152-25-001776 | |
| us-gaap | ShortTermNonBankLoansAndNotesPayable | Short-term Non-bank Loans and Notes Payable | USD | 55,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -2.65M | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 83,526 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 54,267 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 35,624 | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 300,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 50,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-10-21 | 0001493152-24-041809 |
| us-gaap | TransferToInvestments | Transfer to Investments | USD | 395,833 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-09-17 | 0001493152-21-022984 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 34.33M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 17.66M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001493152-22-006994 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 34.33M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2025-01-10 | 0001493152-25-001779 |